Seroprevalence of SARS-CoV-2 infections among children visiting a hospital
- PMID: 33376950
- PMCID: PMC7768294
- DOI: 10.1002/ped4.12231
Seroprevalence of SARS-CoV-2 infections among children visiting a hospital
Abstract
Importance: In this study, we retrospectively investigated the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies within serum samples from children in Beijing, China. These findings provide preliminary guidance regarding population susceptibility to SARS-CoV-2, which will aid in establishing policy toward coronavirus disease 2019 (COVID-19) prevention and control.
Objective: To understand the seropositivity of anti-SARS-CoV-2 IgM/IgG antibodies among children in Beijing, China, evaluate the susceptibility of children in Beijing to SARS-CoV-2, and provide prima facie evidence to guide SARS-CoV-2 prevention and control.
Methods: IgM/IgG antibody kits (colloidal gold) were used to conduct preliminary screening of SARS-CoV-2 IgM/IgG antibodies in serum samples of children who presented to Beijing Children's Hospital, Capital Medical University, having fever or requiring hospitalization, from March 2020 to August 2020. Statistical analysis of anti-SARS-CoV-2 antibody seropositivity was performed according to the children's general demographic characteristics, timing of admission to hospital, presence of pneumonia, and viral nucleic acid test results.
Results: The study included 19 797 children with both IgM and IgG antibody results. Twenty-four children had anti-SARS-CoV-2 IgM-positive results (positive rate of 1.2‰), twelve children had anti-SARS-CoV-2 IgG-positive results (positive rate of 0.6‰). Viral nucleic acid test results were negative for the above-mentioned children with positive antibody findings; during the study, two children exhibited positive viral nucleic acid test results, but their anti-SARS-CoV-2 IgM/IgG antibody results were negative. Anti-SARS-CoV-2 IgM antibody seropositivity was higher in the <1-year-old group than in the ≥6-year-old group. The rates of anti-SARS-CoV-2 IgM seropositivity was highest in August from March to August; IgG results did not significantly differ over time. The rates of anti-SARS-CoV-2 IgM or IgG seropositivity among children with and without suspected pneumonia did not significantly differ between groups.
Interpretation: During the study period, the rates of anti-SARS-CoV-2 IgM/IgG antibody seropositivity were low among children who presented to Beijing Children's Hospital, Capital Medical University. The findings suggest that children in Beijing are generally susceptible to SARS-CoV-2 infection; COVID-19 prevention and control measures should be strengthened to prevent disease in children.
Keywords: Antibody; Children; Coronavirus disease 2019 (COVID‐19); Seroprevalence; Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2).
© 2020 Chinese Medical Association. Pediatric Investigation published by John Wiley & Sons Australia, Ltd on behalf of Futang Research Center of Pediatric Development.
Conflict of interest statement
None.
Similar articles
-
The Fluctuation Trend of Serum Anti-SARS-CoV-2 IgM/IgG Antibodies Seroprevalence in the Non-COVID-19 Infected Population and Correlation with Peripheral Blood Leukocyte Parameters in Beijing, China, 2021: A Real-World Study.Vaccines (Basel). 2022 Apr 7;10(4):571. doi: 10.3390/vaccines10040571. Vaccines (Basel). 2022. PMID: 35455320 Free PMC article.
-
Dynamics of Detection of Anti-SARS-CoV-2 IgG/IgM and SARS-CoV-2 RNA in Respiratory Tract Specimens in 48 COVID-19 Patients.Clin Lab. 2021 Nov 1;67(11). doi: 10.7754/Clin.Lab.2021.200732. Clin Lab. 2021. PMID: 34758225
-
[Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing].Zhonghua Er Ke Za Zhi. 2006 Apr;44(4):262-6. Zhonghua Er Ke Za Zhi. 2006. PMID: 16780645 Chinese.
-
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.Int Immunopharmacol. 2020 Sep;86:106746. doi: 10.1016/j.intimp.2020.106746. Epub 2020 Jun 26. Int Immunopharmacol. 2020. PMID: 32619956 Free PMC article.
-
Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.Cancer Treat Rev. 2020 Nov;90:102102. doi: 10.1016/j.ctrv.2020.102102. Epub 2020 Sep 1. Cancer Treat Rev. 2020. PMID: 32947121 Free PMC article. Review.
Cited by
-
Seroprevalence of SARS-CoV-2 infection in pediatric patients in a tertiary care hospital setting.PLoS One. 2024 Sep 24;19(9):e0310860. doi: 10.1371/journal.pone.0310860. eCollection 2024. PLoS One. 2024. PMID: 39316628 Free PMC article.
-
Evolution of SARS-CoV-2 IgG Seroprevalence in Children and Factors Associated with Seroconversion: Results from a Multiple Time-Points Study in Friuli-Venezia Giulia Region, Italy.Children (Basel). 2022 Feb 12;9(2):246. doi: 10.3390/children9020246. Children (Basel). 2022. PMID: 35204966 Free PMC article.
-
The Fluctuation Trend of Serum Anti-SARS-CoV-2 IgM/IgG Antibodies Seroprevalence in the Non-COVID-19 Infected Population and Correlation with Peripheral Blood Leukocyte Parameters in Beijing, China, 2021: A Real-World Study.Vaccines (Basel). 2022 Apr 7;10(4):571. doi: 10.3390/vaccines10040571. Vaccines (Basel). 2022. PMID: 35455320 Free PMC article.
-
Assessment of SARS-CoV-2 Anti-Spike IgG Antibody in Women and Children in Madinah, Saudi Arabia: A Single-Center Study.Int J Environ Res Public Health. 2021 Sep 22;18(19):9971. doi: 10.3390/ijerph18199971. Int J Environ Res Public Health. 2021. PMID: 34639276 Free PMC article.
-
Clinical features and severe acute respiratory syndrome-coronavirus-2 structural protein-based serology of Mexican children and adolescents with coronavirus disease 2019.PLoS One. 2022 Aug 15;17(8):e0273097. doi: 10.1371/journal.pone.0273097. eCollection 2022. PLoS One. 2022. PMID: 35969583 Free PMC article.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239‐1242. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous